Toggle navigation
About
Overview
Enterprise Team
Board of Directors
Partnering
Contact
Disclosures
Programs & Science
Bile Acids and IBAT Inhibition
Pipeline
Bylvay™ (odevixibat)
Elobixibat
Patients & Families
Patient Access
Progressive Familial Intrahepatic Cholestasis (PFIC)
Alagille Syndrome
Biliary Atresia
Chronic (Idiopathic) Constipation
Adult Liver Diseases
Clinical Trials
Funding Requests
Media & Investors
Overview
Press Releases
Events & Presentations
Publications
2021 Annual Meeting
Corporate Governance
Stock Information
Financials & Filings
Analyst Coverage
Contact Us
Careers
Current Openings
Search
Enterprise Team
Ron Cooper
President and Chief Executive Officer
Read More
Martha (Muffy) Carter
Chief Regulatory Officer
Read More
Jason Duncan
Chief Legal Officer and General Counsel
Read More
Jan Mattsson, Ph.D.
Chief Scientific Officer, Managing Director (Sweden), and Co-Founder
Read More
Simon Harford
Chief Financial Officer
Read More
Patrick Horn, M.D., Ph.D.
Chief Medical Officer
Read More
Pamela Stephenson
Chief Commercial Officer
Read More
Michelle Graham
Chief Human Resources Officer
Read More
Joan Connolly
Chief Technology Officer
Read More
